Femara
Payments companies reported to CMS as associated with Femara. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Femara, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Femara
These are the largest totals companies reported as associated with Femara. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Warner Peng | Oxnard, CA | Hematology & Oncology | $29.95 |
| Oscar Signori | Dearborn, MI | Hematology & Oncology | $29.21 |
| Nicholas Demonaco | Clinton, MD | Hematology & Oncology | $28.46 |
| Rita Gupta | Clinton, MD | Hematology & Oncology | $28.46 |
| Keisha Ritter | Brandywine, MD | Family | $28.46 |
| Erin Frank | Hartford, CT | Medical | $28.46 |
| Silver Festin | Columbia, MD | Family | $24.91 |
| Michelle Dusenberry | Massillon, OH | Family | $21.03 |
| Noman Rafique | Massillon, OH | Hematology & Oncology | $21.03 |
| William Conway | Massillon, OH | Family | $21.03 |
Prescribed Femara?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.